Although I don't agree that more modern vaccines are safer, its amazing he
wrote this.
Sheri

http://dailynews.yahoo.com/htx/abc/20011204/hl/smallpox_commentary011204_1.h
tml

Tuesday December 04 07:26 PM EST

Commentary: Smallpox Vaccine Has Risks
By Commentary
By Steven Black, MDSpecial to ABCNEWS.com
Vaccinations may be more dangerous than the disease itself

   
Should Americans be immunized against the smallpox virus in case of a
terrorist attack?


Officials with the U.S. Centers for Disease Control and Prevention say it's
not necessary, yet 50 percent of citizens polled by ABCNEWS say they would
still get the shot if and when the vaccine becomes available. We asked
vaccine expert Dr. Steven Black to explain why nationwide smallpox
vaccinations are not recommended.

Immunizations are among the most widely used and effective public health
measures. Many immunizations in current use, including those for hepatitis
B, polio and whooping cough, have been developed to replace earlier
vaccines and provide a more acceptable safety profile.

Because of the continuous safety review process and the application of new
technologies in vaccine development, the vaccines we currently use
routinely are more effective against more diseases, and are safer than ever.

However, vaccines are not always without dangers.

The vaccine for smallpox was developed at the end of the 18th century and
was last routinely used 30 years ago, in the 1970s, before the disease was
eradicated worldwide in 1977. The vaccine provides protection against the
dreaded risk of smallpox - a disease that killed one out of three people it
infected and left most others with lifelong scars or disabilities.

Because of the high risk of smallpox disease and the limits of vaccine
technology in the first half of the 20th century, people accepted the
dangers associated with routine smallpox vaccination, which were more than
outweighed by the ever-present threat of smallpox death.


Small, But Significant Risk of Death

Unfortunately, the smallpox vaccine is just not as safe as any of the other
vaccines routinely used in the United States today.

The vaccine injection causes a red, tender and crusting reaction at the
vaccination skin site that lasts up to two weeks.

More importantly, one out of 150,000 smallpox vaccination recipients
experiences more severe reactions, including overwhelming infection due to
the vaccine virus in individuals with abnormal immune systems, encephalitis
or brain infection. Another one out of 500,000 individuals will die as a
direct cause of the vaccine.

Although the risk of either death or these severe side effects may sound
relatively rare, vaccination of the entire U.S. population would result in
600 deaths and 2,000 individuals with serious brain infections. These very
real risks must be balanced against what is currently only a theoretical
risk of smallpox being introduced by terrorists.



U.S. Smallpox Plan Is Effective

Apart from the hazardous side effects, another reason not to recommend
nationwide prophylactic vaccinations is the strong likelihood that the
disease can be restrained and managed if an initial case is identified.

The strategy U.S. health officials plan to use is to vaccinate individuals
in a "ring" around any cases that are identified, including family,
friends, and co-workers. This strategy will effectively control and
eventually eliminate infection while exposing the smallest number of people
possible to the risks of vaccination.

In addition, it is known that individuals exposed to smallpox can be
protected against illness if they are vaccinated within a few days after
exposure. Therefore, we have no need to expose the entire U.S. population
to the risks of smallpox vaccination with the current vaccine.

It makes much more sense to stockpile enough vaccine to vaccinate only when
and if the threat becomes real. This vaccine stockpile can serve as an
effective deterrent against terrorism and buy us the time that is needed to
develop a safer smallpox vaccine that could be acceptable for general use.


Dr. Steven Black is co-director of the Kaiser Permanente Vaccine Study
Center in Oakland, Calif.



Copyright 2001 ABCNEWS.com.